Recent trends and future perspectives in isolated hepatic perfusion in the treatment of liver tumors.
Isolated hepatic perfusion (IHP) involves a method of complete vascular isolation of the liver to enable treatment of liver tumors with high drug doses without systemic toxicity. Recent clinical studies have mainly employed IHP with melphalan with or without tumor necrosis factor-alpha and mild hyperthermia. The results of these studies demonstrate that high response and survival rates can be achieved with IHP. The current status, recent developments and future perspectives of IHP are discussed in this review.
Rothbarth
J
J
Department of Surgery, K6-R, Leiden University Medical Center, The Netherlands. jrothbarth@gmail.com
Tollenaar
R A E M
RA
van de Velde
C J H
CJ
D000818:Animals; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000379:methods / Q000639:trends*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000453:epidemiology / Q000601:surgery; D010477:Perfusion; D016032:Randomized Controlled Trials as Topic / Q000379:methods / Q000639:trends*